Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Devraj Chavda

Neurology with Special Qualifications in Child Neurology Las Vegas, NV Medical Doctor

NPI 1558814889 CMS profile 11312138

6330 W Flamingo Rd, Las Vegas, NV 89103

Open in the dashboard

General payments

$7,369

225 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Devraj Chavda of Las Vegas, NV is reported in the CMS Open Payments database as having received $7,369 across 225 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,997 79
2024 General $2,165 68
2023 General $1,842 62
2022 General $365 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Devraj Chavda
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Devraj Chavda were reported at $2,997. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Devraj Chavda Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $0 $262 $68–$1,313 $163
2020 $0 $188 $46–$1,222 $114
2021 $0 $183 $45–$1,356 $132
2022 $365 $229 $72–$1,177 $149
2023 $1,842 $269 $93–$1,195 $160
2024 $2,165 $300 $98–$1,428 $164
2025 $2,997 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Jazz Pharmaceuticals Inc. $1,814 24 payments
  2. UCB, Inc. $1,189 38 payments
  3. NS Pharma, Inc. $440 11 payments
  4. ACADIA Pharmaceuticals Inc $427 20 payments
  5. LivaNova USA, Inc. $374 7 payments
  6. SK Life Science, Inc. $336 8 payments
  7. Sarepta Therapeutics, Inc. $294 9 payments
  8. Biogen, Inc. $259 11 payments
  9. Catalyst Pharmaceuticals, Inc. $257 13 payments
  10. Neurelis, Inc. $239 10 payments
  11. Other $1,740 74 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $6,496 221 payments
  2. Travel and Lodging $872 3 payments
  3. Education $1 1 payment
Products named General payments · program years 2022–2025
  1. Epidiolex $1,782 22 payments
  2. Fintepla $654 19 payments
  3. Briviact $523 18 payments
  4. VILTEPSO $440 11 payments
  5. DAYBUE $427 20 payments
  6. VNS THERAPY SENTIVA MODEL 1000 GENERATOR $306 4 payments
  7. SPINRAZA $259 11 payments
  8. VALTOCO $239 10 payments
  9. EMFLAZA $224 9 payments
  10. Evrysdi $209 8 payments
  11. Other $1,587 69 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

225 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record